Update on Research Compliance Software Transition






Research Made Easier

Announcing a Transition to New Research Compliance Software for Human Subjects Research

We are excited to announce the Human Research Protection Program (HRPP) is transitioning to a new software solution—Cayuse— during the spring/summer of 2022! Researchers are already experienced using Cayuse as this software is utilized for our pre-award functions and conflicts of interest. By implementing Cayuse for HRPP, the Research Office will be taking a significant step toward providing a better user experience and linking research integrity functions with pre-award functions.  

This module will provide a flexible, integrated IT platform that will facilitate broader program and process improvements aimed at shortening review times, improving transparency, and reducing the administrative work for researchers.

Cayuse Human Ethics will:

•    streamline the IRB submission process
•    provide a simplified submission process for Exempt studies
•    increased transparency and improved access to IRB review status

Important Information for Current iRIS Users:

Please continue to use iRIS for your HRPP (IRB) and Animal Program Office (IACUC) submissions until further notice.

Anticipated Timeline for Transition to Cayuse:

 We anticipate that the HRPP module will likely go live in Summer of 2022. More information will be provided in the coming months as we get closer to the go-live date.


Cayuse Sponsored Projects:

After the transition to Cayuse Human Ethics is complete, we will move to the modernized Cayuse Sponsored Programs platform to provide a better proposal submission experience and full integration with the other Cayuse modules.

We look forward to bolstering OSU’s commitment to research by implementing this exciting software in partnership with the research community.

Contact Information:

If you have questions, please contact Christopher Viggiani, PhD, Associate Vice President for Research Integrity at Christopher.viggiani@oregonstate.edu.